glp 1 clinical trial Timeline of GLP-1 discovery and development. (a) Key events in Frontiers | The agony and

At baseline, most initiators began treatment with liraglutide (61.9%), followed by semaglutide (22.5%), dulaglutide (11.7%), exenatide (2.4%) and lixisenatide (1.5%)

4.1 GSH/GSSG Regulation in Cancer, Treatment Resistance, and Ferroptosis Some cancer cells increase SLC7A11-dependent cystine uptake, GSH synthesis, NADPH production, or glutathione peroxidase activity under oxidative pressure

Pharmaceuticals 18, 650

Reduced activities and enhanced cellular stress in the mPFC neurons by GSTM1 knockdown in astrocytes Activation of astrocytes and microglia during brain inflammation affects neuronal health and activities